What question did this study set out to answer?

To determine if switching from aspirin to another antithrombotic regimen reduces the recurrence of ischemic stroke.

April 10, 2026

After ischemic stroke in patients receiving aspirin, switching to another antithrombotic regimen does not reduce recurrence

Key Result

Switching to another antithrombotic regimen after an ischemic stroke in patients already receiving aspirin does not reduce the risk of recurrence.

Key Points

To determine if switching from aspirin to another antithrombotic regimen reduces the recurrence of ischemic stroke.
Observational analysis of ischemic stroke patients
Comparison of antithrombotic regimens
Assessment of recurrence rates
No significant reduction in stroke recurrence after switching regimens
Stable recurrence rates observed among patients on aspirin
Implications for antithrombotic management following ischemic stroke

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

GIM/FP/GP:Formula: see text Neurology:Formula: see text Hematology:Formula: see text.

KI fragen

Bookmark

Cite This Study

Shaik et al. (Mon,) reported a other. Switching to another antithrombotic regimen after an ischemic stroke in patients already receiving aspirin does not reduce the risk of recurrence.

synapsesocial.com/papers/69d892d16c1944d70ce040ec https://doi.org/https://doi.org/10.7326/annals-26-00772-jc

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark